286 related articles for article (PubMed ID: 24596316)
21. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
22. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
[TBL] [Abstract][Full Text] [Related]
23. Long-term functional and quality of life evaluation after treatment for advanced pharyngolaryngeal carcinoma.
Metreau A; Louvel G; Godey B; Le Clech G; Jegoux F
Head Neck; 2014 Nov; 36(11):1604-10. PubMed ID: 24115115
[TBL] [Abstract][Full Text] [Related]
24. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
25. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
26. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
27. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
[TBL] [Abstract][Full Text] [Related]
29. Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
Almadori G; Lauriola L; Coli A; Bussu F; Gallus R; Scannone D; Valentini V; Paludetti G; Carey TE; Ranelletti FO
Head Neck; 2017 Apr; 39(4):684-693. PubMed ID: 28032719
[TBL] [Abstract][Full Text] [Related]
30. Effect of daily fraction size on laryngoesophageal dysfunction after chemoradiation for squamous cell carcinomas of the larynx and hypopharynx.
Chen AM; Hsu S; Meshman J; Chin R; Beron P; Abemayor E; St John M
Head Neck; 2017 Jul; 39(7):1322-1326. PubMed ID: 28301066
[TBL] [Abstract][Full Text] [Related]
31. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.
Canis M; Martin A; Ihler F; Wolff HA; Kron M; Matthias C; Steiner W
Head Neck; 2014 Jun; 36(6):859-66. PubMed ID: 23720321
[TBL] [Abstract][Full Text] [Related]
32. Survival outcome depending on different treatment strategies in advanced stages III and IV laryngeal cancers: an audit of data from two European centres.
Karlsson TR; Al-Azzawe M; Aziz L; Hurman D; Finizia C
Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):547-54. PubMed ID: 23995705
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
[TBL] [Abstract][Full Text] [Related]
35. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.
van der Laan TP; Plaat BE; van der Laan BF; Halmos GB
Head Neck; 2015 May; 37(5):707-15. PubMed ID: 24596175
[TBL] [Abstract][Full Text] [Related]
36. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
Zhu J; Fedewa S; Chen AY
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
[TBL] [Abstract][Full Text] [Related]
37. Long-term functional outcome after laryngeal cancer treatment.
Anschuetz L; Shelan M; Dematté M; Schubert AD; Giger R; Elicin O
Radiat Oncol; 2019 Jun; 14(1):101. PubMed ID: 31186027
[TBL] [Abstract][Full Text] [Related]
38. Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx.
Gorphe P; Blanchard P; Breuskin I; Temam S; Tao Y; Janot F
J Laryngol Otol; 2015 Sep; 129(9):903-9. PubMed ID: 26201253
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma of the subglottis.
Garas J; McGuirt WF
Am J Otolaryngol; 2006; 27(1):1-4. PubMed ID: 16360814
[TBL] [Abstract][Full Text] [Related]
40. Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and François Baclesse Cancer Care Center between 1998 and 2008.
Cuny F; Meunier A; Heutte N; Rame JP; De Raucourt D; Babin E; Blanchard D
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):129-34. PubMed ID: 25838235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]